Antibodies to CSP have been directly shown to confer protection against infection in animal malaria models [7, 8], have had some association with protection in human vaccine trials [9], and can be acquired through natural exposure to malaria [10, 11]. This evidence concerns the gene DNAJC5 and malaria.